FIELD: medicine.
SUBSTANCE: means is a product of the chemical modification of 2-hydroxyethylated starch (O-(2-hydroxyethyl)-(1→4)-α-D-glucan) with a molecular weight of 200 kDa, fragments of 2,6-diisobornyl-4-methylenephenol (4-hydroxy-3,5-di(1,7,7-trimethylbicyclo[2.2.1]hept-exo-2-yl)benzyl), wherein the covalently bound fragment of 2,6-diisobornyl-4-methylenephenol content in the said product may be from 0.5 to 6.0 wt %.
EFFECT: invention can be used to increase cerebral blood flow under the conditions of total transient ischemia with reperfusion.
1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT POSSESSING NEUROPROTECTIVE ACTIVITY | 2018 |
|
RU2701739C1 |
| DRUG WITH COMPLEX PHARMACOLOGICAL EFFECT FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, CORRECTION OF CEREBRAL CIRCULATION DISORDERS, TREATMENT OF CONSEQUENCES OF CEREBROVASCULAR DISEASES (OPTIONS) | 2019 |
|
RU2757874C1 |
| AGENT IMPROVING RHEOLOGICAL PROPERTIES OF BLOOD | 2013 |
|
RU2546297C1 |
| PHARMACEUTICAL INJECTION FORM OF HYDROPHILIC CONJUGATE OF HYDROXYETHYLAMYLUM AND 2,6-DIISOBORNYL-4-METHYLPHENOL, METHOD FOR ITS PRODUCTION AND APPLICATIONS FOR CARDIOVASCULAR DISEASES TREATMENT | 2016 |
|
RU2625039C1 |
| AGENT RELIEVING POSTINFARCTION MYOCARDIAL REMODELING | 2020 |
|
RU2740895C1 |
| MEDICATION FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2014 |
|
RU2555335C9 |
| HYDROPHILIC CONJUGATE OF HYDROXYETHYL STARCH AND 2,6-DIISOBORNYL-4-METHYLPHENOL | 2012 |
|
RU2497828C1 |
| HYDROPHILIC CONCENTRATE OF DERIVATIVE STARCH, AND 2,6-DIIZZBORNIL-4-METHYLPHENOL AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2619934C2 |
| NOVEL DERIVATIVES OF 2,6-DI-ISOBORNYL PHENOL AND METHOD OF OBTAINING THEREOF | 2012 |
|
RU2516699C2 |
| METHOD FOR SIMULATING GLOBAL CEREBRAL ISCHEMIA IN RATS | 2014 |
|
RU2544369C1 |
